Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates

19 Mar 2016

Abstract excerpt

Hepatoblastoma (HB) is very rare but the most common malignant neoplasm of the liver occurring in children. Despite improvements in therapy, outcomes for patients with advanced HB that is refractory to standard preoperative chemotherapy remain unsatisfactory. To improve the survival rate among this group, identification of novel prognostic markers and therapeutic targets is needed. We have previously reported...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Epigenetics and DNA Methylation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26991471
DOI: 10.1111/cas.12928

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidatesPMID 26991471Read ↗

Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroupsSemantic proximity Read ↗

Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targetsSemantic proximity Read ↗

RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients.Semantic proximity Read ↗

DNA methylation as a key epigenetic player for hepatoblastoma characterizationSemantic proximity Read ↗

DNA methylation‐based prognosis and epidrivers in hepatocellular carcinomaSemantic proximity Read ↗

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implicationsSemantic proximity Read ↗

Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinomaSemantic proximity Read ↗

Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma.Semantic proximity Read ↗

PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastomaSemantic proximity Read ↗

Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide searchSemantic proximity Read ↗

Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy.Semantic proximity Read ↗

DNA methylation and gene expression profiling highlight retinol metabolism's vital role in Hepatocellular carcinoma developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.